MBOT GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Microbot Medical Inc
Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies
Microbot Medical Inc. is a pre-commercial stage medical technology company with a vision to improve the quality of care for millions of patients and providers globally. The Company has developed the world’s first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems.
Current Price
$1.85
+0.00%Profile
Valuation (TTM)
Market Cap$124.24M
P/E-8.74
EV—
P/B1.60
Shares Out67.16M
P/Sales1183.26
Revenue$105000.00
EV/EBITDA—
Microbot Medical Inc (MBOT) Quality Analysis
MBOT Profitability
Profitability trend analysis coming soon
MBOT Growth
Growth trend analysis coming soon
MBOT Financial Health
Financial health indicators coming soon
MBOT Quality & Fundamental Analysis
Microbot Medical Inc (MBOT) is a Healthcare company in the Medical Instruments & Supplies industry, listed on NASDAQ. This quality analysis page evaluates Microbot Medical Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Microbot Medical Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of -13535.24% and a return on equity (ROE) of -18.33%. Return on assets (ROA) stands at -17.43%.
The debt-to-equity ratio is 0.01, with a current ratio of 23.33.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Microbot Medical Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.